glp-1 fda approved for weight loss Approves Oral Semaglutide as First Pill Weight-loss GLP-1 pill approved for

The growth of compounding also highlighted a longstanding tension in biopharma: patent exclusivity is designed to reward costly R&D, yet high prices and uneven coverage can create strong pressure for workarounds

That is so typical

2025;48:zsae280

Increased enforcement could reduce the number of low-quality vendors, which would potentially increase average prices while simultaneously improving average quality

An updated meta-analysis of cohort studies: diabetes and risk of Alzheimers disease

Whilst the UK advises that women using GLP-1 receptor agonists should avoid pregnancy and use effective contraception, this advice is not being followed consistently in Australian clinical practice, says Associate Professor Luke Grzeskowiak